Antibody-Drug Conjugates Market Size, Share, Growth, and Industry Analysis, By Type (Adcetris, Kadcyla5), By Application (Breast Cancer, Lymphoma), Regional Insights and Forecast From 2026 To 2035

Detailed TOC of Global Antibody-drug Conjugates Market Research Report 2022

1 Antibody-drug Conjugates Market Overview
1.1 Product Overview and Scope of Antibody-drug Conjugates
1.2 Antibody-drug Conjugates Segment by Type
1.2.1 Global Antibody-drug Conjugates Sales Growth Rate Comparison by Type (2022-2035)
1.2.2 Adcetris
1.2.3 Kadcyla
1.3 Antibody-drug Conjugates Segment by Application
1.3.1 Global Antibody-drug Conjugates Sales Comparison by Application: (2022-2035)
1.3.2 Breast Cancer
1.3.3 Lymphoma
1.4 Global Antibody-drug Conjugates Market Size Estimates and Forecasts
1.4.1 Global Antibody-drug Conjugates Revenue 2017-2035
1.4.2 Global Antibody-drug Conjugates Sales 2017-2035
1.4.3 Antibody-drug Conjugates Market Size by Region: 2017 Versus 2021 Versus 2035
2 Antibody-drug Conjugates Market Competition by Manufacturers
2.1 Global Antibody-drug Conjugates Sales Market Share by Manufacturers (2017-2022)
2.2 Global Antibody-drug Conjugates Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Antibody-drug Conjugates Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Antibody-drug Conjugates Manufacturing Sites, Area Served, Product Type
2.5 Antibody-drug Conjugates Market Competitive Situation and Trends
2.5.1 Antibody-drug Conjugates Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Antibody-drug Conjugates Players Market Share by Revenue
2.5.3 Global Antibody-drug Conjugates Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antibody-drug Conjugates Retrospective Market Scenario by Region
3.1 Global Antibody-drug Conjugates Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Antibody-drug Conjugates Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Antibody-drug Conjugates Market Facts & Figures by Country
3.3.1 North America Antibody-drug Conjugates Sales by Country
3.3.2 North America Antibody-drug Conjugates Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Antibody-drug Conjugates Market Facts & Figures by Country
3.4.1 Europe Antibody-drug Conjugates Sales by Country
3.4.2 Europe Antibody-drug Conjugates Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Antibody-drug Conjugates Market Facts & Figures by Region
3.5.1 Asia Pacific Antibody-drug Conjugates Sales by Region
3.5.2 Asia Pacific Antibody-drug Conjugates Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Antibody-drug Conjugates Market Facts & Figures by Country
3.6.1 Latin America Antibody-drug Conjugates Sales by Country
3.6.2 Latin America Antibody-drug Conjugates Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Antibody-drug Conjugates Market Facts & Figures by Country
3.7.1 Middle East and Africa Antibody-drug Conjugates Sales by Country
3.7.2 Middle East and Africa Antibody-drug Conjugates Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Antibody-drug Conjugates Historic Market Analysis by Type
4.1 Global Antibody-drug Conjugates Sales Market Share by Type (2017-2022)
4.2 Global Antibody-drug Conjugates Revenue Market Share by Type (2017-2022)
4.3 Global Antibody-drug Conjugates Price by Type (2017-2022)
5 Global Antibody-drug Conjugates Historic Market Analysis by Application
5.1 Global Antibody-drug Conjugates Sales Market Share by Application (2017-2022)
5.2 Global Antibody-drug Conjugates Revenue Market Share by Application (2017-2022)
5.3 Global Antibody-drug Conjugates Price by Application (2017-2022)
6 Key Companies Profiled
6.1 ImmunoGen
6.1.1 ImmunoGen Corporation Information
6.1.2 ImmunoGen Description and Business Overview
6.1.3 ImmunoGen Antibody-drug Conjugates Sales, Revenue and Gross Margin (2017-2022)
6.1.4 ImmunoGen Antibody-drug Conjugates Product Portfolio
6.1.5 ImmunoGen Recent Developments/Updates
6.2 Seattle Genetics
6.2.1 Seattle Genetics Corporation Information
6.2.2 Seattle Genetics Description and Business Overview
6.2.3 Seattle Genetics Antibody-drug Conjugates Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Seattle Genetics Antibody-drug Conjugates Product Portfolio
6.2.5 Seattle Genetics Recent Developments/Updates
6.3 Roche
6.3.1 Roche Corporation Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche Antibody-drug Conjugates Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Roche Antibody-drug Conjugates Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Takeda
6.4.1 Takeda Corporation Information
6.4.2 Takeda Description and Business Overview
6.4.3 Takeda Antibody-drug Conjugates Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Takeda Antibody-drug Conjugates Product Portfolio
6.4.5 Takeda Recent Developments/Updates
7 Antibody-drug Conjugates Manufacturing Cost Analysis
7.1 Antibody-drug Conjugates Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Antibody-drug Conjugates
7.4 Antibody-drug Conjugates Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Antibody-drug Conjugates Distributors List
8.3 Antibody-drug Conjugates Customers
9 Antibody-drug Conjugates Market Dynamics
9.1 Antibody-drug Conjugates Industry Trends
9.2 Antibody-drug Conjugates Market Drivers
9.3 Antibody-drug Conjugates Market Challenges
9.4 Antibody-drug Conjugates Market Restraints
10 Global Market Forecast
10.1 Antibody-drug Conjugates Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Antibody-drug Conjugates by Type (2023-2035)
10.1.2 Global Forecasted Revenue of Antibody-drug Conjugates by Type (2023-2035)
10.2 Antibody-drug Conjugates Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Antibody-drug Conjugates by Application (2023-2035)
10.2.2 Global Forecasted Revenue of Antibody-drug Conjugates by Application (2023-2035)
10.3 Antibody-drug Conjugates Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Antibody-drug Conjugates by Region (2023-2035)
10.3.2 Global Forecasted Revenue of Antibody-drug Conjugates by Region (2023-2035)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer